PRESS RELEASE published on 04/20/2023 at 22:05, 2 years 10 months ago Moderna to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023
PRESS RELEASE published on 04/20/2023 at 13:30, 2 years 10 months ago Moderna and IBM to Explore Quantum Computing and Generative AI for mRNA Science
PRESS RELEASE published on 04/16/2023 at 17:00, 2 years 11 months ago Moderna and Merck Announce mRNA-4157 (V940), an Investigational Individualized Neoantigen Therapy, in Combination with KEYTRUDA(R) (Pembrolizumab), Demonstrated Superior Recurrence-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following C
PRESS RELEASE published on 04/11/2023 at 13:00, 2 years 11 months ago Moderna Announces Clinical and Program Updates at 4th Vaccines Day
PRESS RELEASE published on 04/06/2023 at 23:00, 2 years 11 months ago MRNA-4157/V940, an Investigational Personalized MRNA Cancer Vaccine, in Combination With Keytruda(R) (Pembrolizumab), Receives Prime Scheme Designation From the European Medicines Agency for Adjuvant Treatment of Patients With High-Risk Stage III/IV Melan
PRESS RELEASE published on 03/30/2023 at 13:00, 2 years 11 months ago Moderna Finalizes Agreement with the Government of the Republic of Kenya to Establish an mRNA Manufacturing Facility
PRESS RELEASE published on 03/24/2023 at 12:30, 2 years 11 months ago Moderna to Host Fourth Annual Virtual Vaccines Day on April 11, 2023
PRESS RELEASE published on 03/23/2023 at 12:02, 2 years 11 months ago Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines
PRESS RELEASE published on 03/14/2023 at 22:40, 3 years ago Moderna Announces Phase 2 Data on mRNA-4157/V940, an Investigational mRNA Personalized Cancer Vaccine, to be Presented at the 2023 AACR Annual Meeting
PRESS RELEASE published on 03/10/2023 at 17:00, 3 years ago Moderna Outlines Commitment to Corporate Growth and Announces U.S. Expansion in 2023
Published on 03/18/2026 at 14:30, 2 hours 29 minutes ago Ground Geophysics Underway at Murphy Lake, 5 km From Isoenergy's Hurricane Deposit, Athabasca Basin
Published on 03/18/2026 at 14:15, 2 hours 44 minutes ago Apex Provides Phase I Drilling Update at the Rift Rare Earth Project in Nebraska, U.S.A.
Published on 03/18/2026 at 14:00, 2 hours 59 minutes ago Route1 Announces Filing of Parking Copilot Patent Application and Confirms Expected Launch Date for "Mr. Parking"
Published on 03/18/2026 at 14:00, 2 hours 59 minutes ago FDA Feedback Supports Extension Phase for Jaguar Health's Clinical Trial of Crofelemer for Treatment of Microvillus Inclusion Disease (MVID)
Published on 03/18/2026 at 13:30, 3 hours 29 minutes ago Predictiv AI Launches AGORACOM Marketing Program and Engages Venture Liquidity Partners for Market Making
Published on 03/18/2026 at 16:35, 23 minutes ago Ferrero Group acquires Bold Snacks, a leading Brazilian protein snack company
Published on 03/18/2026 at 15:34, 1 hour 25 minutes ago thyssenkrupp nucera Supplies Electrolyzers for Moeve to Build Southern Europe’s Largest Green Hydrogen Project
Published on 03/18/2026 at 14:25, 2 hours 33 minutes ago Ethisphere recognizes Infosys among 2026 World's Most Ethical Companies®
Published on 03/18/2026 at 14:25, 2 hours 34 minutes ago PSI postpones the release of its 2025 annual and consolidated financial statements until the end of April 2026
Published on 03/18/2026 at 14:20, 2 hours 38 minutes ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc
Published on 03/18/2026 at 07:00, 9 hours 59 minutes ago Mersen: A resilient performance in 2025, return to growth expected in 2026
Published on 03/17/2026 at 07:00, 1 day 9 hours ago Invitation to the Extraordinary General Meeting of shareholders
Published on 03/16/2026 at 18:00, 1 day 22 hours ago Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 1 day 23 hours ago Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 1 day 23 hours ago Reporting on share buyback transactions carried out between March 9 and March 13, 2026
